| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $300K | — |
| Cost of Revenue | $273K | -74.5% |
| Gross Profit | $27K | — |
| R&D Expense | $3K | -85.0% |
| SG&A Expense | $826K | -25.2% |
| Operating Income | -$802K | +28.6% |
| Net Income | -$726K | +34.1% |
| EPS (Basic) | -$0.02 | +66.7% |
| EPS (Diluted) | -$0.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -19.9% |
| Current Assets | $2.3M | -20.9% |
| Total Assets | $2.5M | -17.1% |
| Current Liabilities | $311K | +19.2% |
| Total Liabilities | $671K | +18.6% |
| Stockholders' Equity | $1.8M | -25.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$548K | +18.5% |
| Capital Expenditures | $18K | -48.6% |
| Investing Cash Flow | -$18K | +48.6% |
| Free Cash Flow | -$566K | +19.9% |
| +0.0% |